Table 4.
Unadjusted and Adjusted Association between method of contraception and trichomoniasis
| Contraceptive method (time-varying) |
Non- Trichomoniasis intervals (%) |
Trichomoniasis intervals (%) |
cHR (95% CI) |
aHR# (95% CI) |
|---|---|---|---|---|
| Non-hormonal‡ | 5626 (77%) | 489 (85%) | Ref | Ref |
| DMPA | 659 (9%) | 18 (3%) | 0.38*** (0.22-0.65) | 0.43** (0.25-0.74) |
| Implant | 45 (1%) | 2 (0%) | 0.62 (0.10-3.73) | ---- |
| OCPs | 981 (13% | 65 (11%) | 0.87 (0.63-1.20) | 0.95 (0.7-1.31) |
OCP: oral contraceptive pill; IUD: copper intrauterine device; DMPA: Depot Medroxyprogesterone Acetate; cHR: crude hazard ratio; aHR: adjusted hazard ratio; CI: confidence interval
Controlling for women’s HIV status, pregnancy status, breastfeeding, active genital ulcer, bacterial vaginosis, and vaginal candidiasis
no method, condoms, permanent (excludes copper intrauterine devices)
p-value<0.05
p-value<0.01
p-value<0.001.
Number of events in Implant group too few to allow for adjusted estimates